Hanall Biopharma Co.,Ltd (009420.KS) - Stock Prices, Stock Peers & Analysis

Home
009420.KS

Company Name	Hanall Biopharma Co.,Ltd
Symbol	009420.KS
Currency	KRW
Price	36,000
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	1,825,511,832,000
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	24,650 - 46,750
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Sean Jeong
Website	https://www.hanall.co.kr

An error occurred while fetching data.

About Hanall Biopharma Co.,Ltd

Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes,